|
Kendle has the expertise to provide the following Late Phase services in all major therapeutic areas:
- Phase IIIB Trials
- New indications
- New formulations
- Head-to-head comparative studies
- Medical outcomes
- Phase IV Studies
- Health outcomes research
- Quality of life
- Expanded access program
Our 25+ years of experience includes designing and conducting more than 600 Phase IIIB/IV clinical trials worldwide and recruiting more than 1.5 million patients. We pride ourselves on strong, experienced project leadership and our ability to provide targeted feasibility and contingency plans to ensure trials are completed to the highest standards and within the specified timeframe.
Our global reach and experience enables us to conduct large international studies and access specific patient populations globally, while using our local expertise to meet national requirements.
Involvement in the study design phase enables us to offer cost efficiencies related to Case Report Form (CRF) content and data capture. We also can provide site support through our Study Coordination Center, achieving further efficiencies through a hybrid approach of on-site and centralized monitoring activities.
Kendle’s innovative approaches to mega-trial management can help customers realize further significant cost efficiencies. Our well-established site selection group is expert in rapid start-up and retention. We supplement on-site monitoring with in-house site management, enabling strong project oversight while at the same time reducing expenses.
|
